• Home
  • Recruiting Trials

Recruiting Trials

Research Area
Study Name
Basic Eligibility
Doctors Referral
Participant Enquiry

Cardiology

Research Area:
Cardiology
Heart Failure
Study Name:
Heart-FID (1VIT15043)
Basic Eligibility:
Age over 18
Heart Failure
Mobile with or without mobility aid
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Cardiology
Heart Failure
Study Name:
SODIUM-HF
Basic Eligibility:
Age 18 or over
Confirmed diagnosis of Heart Failure
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.

Research Area:
Cardiology
Coronary Artery Lesions
Study Name:
DynamX Sirolimus (ELX-CL-1801)
Basic Eligibility:
Age 18 or over
Evidence of myocardial ischemia
Acceptable candidate for coronary artery bypass surgery
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Middlemore Hospital.

Research Area:
Cardiology
Acute Coronary Syndrome
Study Name:
AEGIS-II (CSL112_3001)
Basic Eligibility:
Type 1 Myocardial infarction
Have at least two coronary artery territories of disease > 50%
Be on treatment for Diabetes
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Middlemore Hospital.

Diabetes

Research Area:
Diabetes
Type 2 Diabetes
Study Name:
WORTH
Basic Eligibility:
Aged between 18 & 80 years old
Type 2 diabetes for at least 12 months
Taking Metformin and/or sulphonylures
No change in diabetes treatment within previous 3 months
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Gastroenterology

Research Area:
Gastroenterology
Crohn's Disease
Study Name:
RISA (M15-991)
Basic Eligibility:
Moderate to severe abdominal pain and/or daily unformed stool frequency >4
Previous biologic failure or intolerance (e.g. to infliximab or Humira)
No ileostomy/colostomy
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Haematology

Research Area:
Haematology
Chronic Lymphocytic Leukemia / Small Lymphocytic Leukemia
Study Name:
Alpine (BGB-3111-305)
Basic Eligibility:
Age 18 or over
Have confirmed diagnosis of CLL or SLL
Show signs of active progression from last line of treatment (as measured by your doctor)
Must not require long term steroid use
Be active (not sitting/lying down) for >50% of the day
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.

Research Area:
Haematology
Mantle Cell Lymphoma
Study Name:
Acerta 308 (ACE-LY-308)
Basic Eligibility:
Age over 65 years
Diagnosed Mantle Cell Lymphoma
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.

Research Area:
Haematology
Follicular Lymphoma
Study Name:
FL212 (BGB-3111-212)
Basic Eligibility:
Age over 18 years
Diagnosed Follicular Lymphoma
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.

Hepatology

Research Area:
Hepatology
Fatty Liver
Study Name:
AURORA (3152-301-002)
Basic Eligibility:
Aged 18 - 75 years
Diagnosed with NASH or ‘Fatty Liver’
Do not have HIV, Cirrhosis, Hepatitis B or C
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Hepatology
Fatty Liver
Study Name:
REVERSE (747-304)
Basic Eligibility:
Age 18 or over
Stage 4 fatty liver
No recent history of significant alcohol consumption
No evidence of other known forms of chronic liver disease
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Hepatology
Chronic Hepatitis B
Study Name:
DCR-HBVS-101, GS-US-493-5342, VIR (VIR-2218), YP (YP39364)
Basic Eligibility:
Age 18 to 65
Chronic Hepatitis B infection
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Lipidology

Research Area:
Lipidology
Dislipidemia
Study Name:
AROANG1001, AROAPOC31001
Basic Eligibility:
Age 18 to 65
Diagnosis of Familial hypercholesterolemia
BMI 19 to 37kg/m2
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.

Neonatal

Research Area:
Neonatal
Neonatal care
Study Name:
ABC
Basic Eligibility:
Infants born at less than 31 weeks
Has delayed cord clamping
Non regular rhythmic breathing
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible premature infants at delivery.

Research Area:
Neonatal
Neonatal care
Study Name:
PAEAN
Basic Eligibility:
Infants born at or more than 35 weeks
Indication of perinatal depression
Moderate to severe encephalopathy
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible premature infants at delivery.

Otolaryngology (ENT)

Research Area:
Otolaryngology (ENT)
Chronic Sinusitis
Study Name:
LYR-210
Basic Eligibility:
Age over 18
Meet diagnostic criteria for chronic sinusitis
Had at least two trials of medical treatments in the past (one of which must be intranasal corticosteroid sprays for at least 4 weeks)
No previous sinuplasty or endo-nasal surgery other than septoplasty or surgical manipulation to nasal turbinates
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Paediatrics

Research Area:
Paediatrics
Viral Respiratory Disease
Study Name:
SHIVERS
Basic Eligibility:
Viral respiratory disease
Acute presentation to Middlemore Emergency Department or Intensive care unit
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients with acute presentation at Middlemore Hospital.

Research Area:
Paediatrics
Rheumatic Fever
Study Name:
Start
Basic Eligibility:
Aged between 5 - 14 years
Newly diagnosed with Acute rheumatic fever
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Middlemore Hospital.

Research Area:
Paediatrics
Acute Hypoxic Respiratory Failure
Study Name:
PARIS 2
Basic Eligibility:
Aged less than 5 years old
Acute hypoxic respiratory failure
Requiring hospital admission
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Kidz First Hospital.

Renal

Research Area:
Renal
End Stage Renal Disease
Study Name:
PDOPPS 2
Basic Eligibility:
Aged over 18 years
Have end stage renal disease;
Receiving chronic, maintenance Peritoneal dialysis
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Renal
Chronic Kidney Disease
Study Name:
Ascend ND 200808
Basic Eligibility:
Age 18 years or over
Have Chronic Kidney Disease
Needing to start on or on erythropoiesis stimulating agents (ESA) replacement therapy
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Respiratory

Research Area:
Respiratory
Bronchiectasis
Study Name:
PROMIS I (Z7224L01)
Basic Eligibility:
Age 18 or over
Have Non-Cystic Fibrosis Bronchiectasis
Have pseudomonas aeruginosa
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Rheumatology

Research Area:
Rheumatology
Psoriatic Arthritis
Study Name:
M16-011 (PSA), M15-998 (PSA)
Basic Eligibility:
Age 18 or over
Psoriatic Arthritis
Swollen and tender joints
Skin psoriasis
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

Research Area:
Rheumatology
Giant Cell Arthritis
Study Name:
Select - GCA (M16-852)
Basic Eligibility:
Age 50 or over
Diagnosed Giant Cell Arthritis
Headache, jaw pain, vision loss
Shoulder and/or hip pain
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify

About Us

Middlemore Clinical Trials (MMCT) is New Zealand's largest clinical trials site, which offers world-class facilities, excellent audited procedures, and a fully integrated research unit.

Our Contacts